Fluid Guided Heart Failure Treatment at the Cleveland Clinic
Fluid Guided Heart Failure Treatment
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 21 Years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Mentioned in the study description
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Mentioned in the study description
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
FIGHT-HF is an exploratory non-randomized open-label study evaluating a heart failure management intervention. The goal of this pilot is to assess the performance of a fluid-guided heart failure management program and Alert Response Guide (ARG) using the Bodyport Cardiac Scale and Congestion Index in 50 adult participants with acute and chronic heart failure, who are followed by a Cleveland Clinic cardiologist.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Official eligibility criteria
Inclusion Criteria: * Hospitalized for acute decompensated heart failure * Age 21 years or older * Able to speak and read English Exclusion Criteria: * New York Heart Association functional class IV symptoms * Received or are scheduled to receive a heart transplant or ventricular assist - device in the next 12 months * Have a glomerular filtration rate of less than 25 mL/min while nonresponsive to diuretic therapy or on chronic renal dialysis * Have a history of regularly scheduled intravenous HF therapy (e.g., inotropes or diuretics) * Have a life expectancy of less than 12 months * Are pregnant or plan to become pregnant during the next 12 months * Weigh greater than 375 lbs * Unable to stand on two bare feet without assistance
Study sites (1)
OH
- The Cleveland Clinic · Cleveland, OH 44195Elaine Franko · Study contact · 216-444-9020 · FRANKOE@ccf.orgMore trials in Cleveland